Axial Biotherapeutics Names New CFO, VP
socalTECH
OCTOBER 31, 2018
Pasadena-based Axial Biotherapeutics , which is developing treatments for neurological diseases, said yesterday that it has named Jeffrey Young as its first Chief Financial Officer (CFO), and appointed Dennis Yamashita, Ph.D., as Vice President, Medicinal Chemistry. Young was most recently CFO, Treasurer, and Secretary at Juniper Pharmaceuticals, and also served at OvaScience, Transmedics, Lantheus Medical Imaging, Critical Therapeutics, PerkinElmer, and PriceWaterhouseCoopers LLP.
Let's personalize your content